SCHEMBL16795653

SCHEMBL16795653

C=C(CCl)c1ccc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
HDAC1 Q13547 4/20 0.51
HDAC8 Q9BY41 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HPGD P15428 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
EGFR P00533 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
JAK1 P23458 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196215 0.83 CES2 (0.52) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL14397447 0.82 PTPN1 (0.61) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL6381436 0.82 SMN1; SMN2 (0.53) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL28655525 0.80 HDAC1 (0.49) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL21382648 0.79 HDAC1 (0.55) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL7905175 0.78 CES2 (0.56) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL8766718 0.78 PTPN1 (0.67) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL30354087 0.78 PTPN1 (0.67) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL8086233 0.77 HDAC1 (0.47) CES2CES1HDAC1HDAC8SMN1; SMN2
SCHEMBL13089410 0.76 HDAC1 (0.64) CES2CES1HDAC1HDAC8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed